Lilia Cordeiro Bastos Silveira

Prevalence of the F508del variant in patients with cystic fibrosis in northeastern Brazil: clinical and laboratory factors

In this sample, the proportion of patients who were homozygous for the F508del mutation was well above the national and international averages, which makes those patients potentially eligible for treatment with at least one CF transmembrane conductance regulator modulator.